ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2019

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1-Biosimilar and Originator Infliximab in the Hospital Setting.

Evelien Moorkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.